EP Patent
EP1293195A1 — Oral pharmaceutical dosage forms with reduced potential for drug abuse, comprising respiratory irritants or bitter substances
Assigned to Rohm and Haas Co · Expires 2003-03-19 · 23y expired
What this patent protects
Solid oral dosage forms of controlled substances containing aversive agents are useful in reducing abuse by chewing or inhaling.
USPTO Abstract
Solid oral dosage forms of controlled substances containing aversive agents are useful in reducing abuse by chewing or inhaling.
Drugs covered by this patent
- OxyContin (oxycodone) · Purdue Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.